W.-D. Illner

814 total citations
40 papers, 542 citations indexed

About

W.-D. Illner is a scholar working on Transplantation, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, W.-D. Illner has authored 40 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Transplantation, 18 papers in Surgery and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in W.-D. Illner's work include Renal Transplantation Outcomes and Treatments (26 papers), Organ Transplantation Techniques and Outcomes (11 papers) and Neurological Complications and Syndromes (8 papers). W.-D. Illner is often cited by papers focused on Renal Transplantation Outcomes and Treatments (26 papers), Organ Transplantation Techniques and Outcomes (11 papers) and Neurological Complications and Syndromes (8 papers). W.-D. Illner collaborates with scholars based in Germany, Switzerland and Austria. W.-D. Illner's co-authors include W. Land, D. Abendroth, H. Schneeberger, Markus Rentsch, Helmut Arbogast, K.‐W. Jauch, Markus Guba, Christian Graeb, C. Wimmer and Alexander Crispin and has published in prestigious journals such as Kidney International, Diabetologia and BMC Complementary and Alternative Medicine.

In The Last Decade

W.-D. Illner

34 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W.-D. Illner Germany 13 246 243 105 93 70 40 542
Groth Cg Sweden 12 251 1.0× 452 1.9× 39 0.4× 49 0.5× 101 1.4× 72 657
Kristene K. Gugliuzza United States 11 301 1.2× 172 0.7× 25 0.2× 55 0.6× 67 1.0× 17 442
G. R. Russ Australia 9 271 1.1× 190 0.8× 80 0.8× 56 0.6× 85 1.2× 18 420
Rossana Caldara Italy 16 276 1.1× 463 1.9× 123 1.2× 82 0.9× 76 1.1× 65 751
Thomas Johnston United States 7 231 0.9× 156 0.6× 91 0.9× 57 0.6× 69 1.0× 29 433
Stiller Cr Canada 12 119 0.5× 123 0.5× 47 0.4× 33 0.4× 53 0.8× 49 467
Michael Cecka United States 13 453 1.8× 333 1.4× 27 0.3× 46 0.5× 210 3.0× 27 656
Marek Myślak Poland 12 298 1.2× 190 0.8× 27 0.3× 32 0.3× 78 1.1× 41 526
Kazuharu Uchida Japan 10 241 1.0× 277 1.1× 41 0.4× 28 0.3× 67 1.0× 11 486
Kyo M Japan 7 157 0.6× 110 0.5× 27 0.3× 37 0.4× 44 0.6× 26 339

Countries citing papers authored by W.-D. Illner

Since Specialization
Citations

This map shows the geographic impact of W.-D. Illner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.-D. Illner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.-D. Illner more than expected).

Fields of papers citing papers by W.-D. Illner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.-D. Illner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.-D. Illner. The network helps show where W.-D. Illner may publish in the future.

Co-authorship network of co-authors of W.-D. Illner

This figure shows the co-authorship network connecting the top 25 collaborators of W.-D. Illner. A scholar is included among the top collaborators of W.-D. Illner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.-D. Illner. W.-D. Illner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kleespies, Axel, Sebastian Pratschke, Andrej Khandoga, et al.. (2017). Moon phases and moon signs do not influence morbidity, mortality and long-term survival, after living donor kidney transplantation. BMC Complementary and Alternative Medicine. 17(1). 440–440. 5 indexed citations
2.
Illner, W.-D., et al.. (2008). Multitransplantation der Nieren: Operationstechnik, Ergebnisse, Komplikationen. DMW - Deutsche Medizinische Wochenschrift. 115(14). 523–527.
3.
Dieterle, C., B Gutt, Helmut Arbogast, et al.. (2007). Impaired Glucose Tolerance in Pancreas Grafted Diabetic Patients is Due to Insulin Secretory Defects. Experimental and Clinical Endocrinology & Diabetes. 115(10). 647–653. 6 indexed citations
4.
Wimmer, C., Markus Rentsch, Alexander Crispin, et al.. (2007). The janus face of immunosuppression – de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. Kidney International. 71(12). 1271–1278. 136 indexed citations
5.
Hillebrand, G, W.-D. Illner, Manfred Stangl, et al.. (2000). [Living donors in kidney transplantation. Renaissance by non-related donors?].. PubMed. 118(4). 135–1. 1 indexed citations
6.
Schneeberger, H., Şöhret Aydemir, Roman‐Ulrich Müller, et al.. (2000). Hyperimmunoglobulin prophylaxis, monitoring and preemptive ganciclovir treatment eliminate the risk of CMV infection to improve patient and renal allograft survival. Transplant International. 13(0). S354–S358. 6 indexed citations
7.
8.
9.
Weninger, E., et al.. (1998). Prolongierte Aufwachphase bei dialyseinduzierter Hypothyreose. AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 33(12). 810–812.
10.
Schneeberger, H., W.-D. Illner, Gunther O. Hofmann, et al.. (1996). Assessment of oxygen radicals during kidney transplantation — effect of radical scavenger. Transplant International. 9 Suppl 1. 479–482. 15 indexed citations
11.
Petersen, Peter, H. Schneeberger, Stefan Schleibner, et al.. (1994). Positive donor and negative recipient cytomegalovirus status is a detrimental factor for long-term renal allograft survival. Transplant International. 7(s1). 336–338. 8 indexed citations
12.
Lange, Volker, H. M. Schardey, G. Meyer, et al.. (1994). Laparoscopic deroofing of post-transplant lymphoceles. Transplant International. 7(2). 140–143. 24 indexed citations
13.
Hillebrand, G, H. Schneeberger, Karim Burkhardt, et al.. (1993). Ten years' experience with cyclosporine monotherapy after renal transplantation.. PubMed. 25(1 Pt 1). 513–4. 7 indexed citations
14.
Burkhardt, Karim, Meinrad Gawaz, H. Schneeberger, et al.. (1993). Thrombospondin and the expression of adhesion molecules in acute and chronic renal transplant rejection.. PubMed. 25(1 Pt 2). 1364–5. 4 indexed citations
15.
Klare, B., Hartmut Hahn, I Engelsberger, et al.. (1991). Remarkable long-term prognosis and excellent growth in kidney-transplant children under cyclosporine monotherapy.. PubMed. 23(1 Pt 2). 1013–7. 37 indexed citations
16.
Illner, W.-D., D. Abendroth, J. Nusser, R. Landgraf, & W. Land. (1991). Long-term results in pancreatic transplantation with special emphasis on the use of prolamine. Diabetologia. 34(S1). S14–S15. 4 indexed citations
17.
Illner, W.-D., D. Abendroth, H. Schneeberger, et al.. (1991). Outcome of renal grafts after simultaneous kidney/ pancreas transplantation. Diabetologia. 34(S1). S16–S17. 1 indexed citations
18.
Schilling, M., et al.. (1990). Quadruple drug induction treatment in patients with ATN-kidneys: expensive but effective.. PubMed. 22(5). 2283–2283. 3 indexed citations
19.
Schneeberger, H., W.-D. Illner, D. Abendroth, et al.. (1989). First clinical experiences with superoxide dismutase in kidney transplantation--results of a double-blind randomized study.. PubMed. 21(1 Pt 2). 1245–6. 28 indexed citations
20.
Land, W., et al.. (1983). [Combined basic immunosuppression following kidney transplantation. Cyclosporin A in combination with azathioprine and methylprednisolone].. PubMed. 125(17). 361–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Groth Cg Breakdown of academic impact, for papers by Kristene K. Gugliuzza Breakdown of academic impact, for papers by G. R. Russ Breakdown of academic impact, for papers by Rossana Caldara Breakdown of academic impact, for papers by Thomas Johnston Breakdown of academic impact, for papers by Stiller Cr Breakdown of academic impact, for papers by Michael Cecka Breakdown of academic impact, for papers by Marek Myślak Breakdown of academic impact, for papers by Kazuharu Uchida Breakdown of academic impact, for papers by Kyo M
Rankless by CCL
2026